Navigation Links
China Biologic Products Appoints Director of Research and Development
Date:9/9/2009

TAI'AN, China, Sept. 9 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. ("Taibang") and Chongqing Dalin Biologic Technologies Co., Ltd. ("Dalin") and its equity investment in Xi'an Huitian Blood Products Co., Ltd. ("Huitian"), today announced that the Company has appointed Dr. Vincent Yi-Wu Xie to be the Company's Director of Research and Development, effective September 1, 2009, to oversee the development of new biologic products covering processes, analytical methods and indications.

Dr. Xie is a veteran in the biopharmaceutical industry and has published several papers and articles related to the field of plasma-based research. He holds a number of patents related to his biopharmaceutical research, including research on plasma-derived hyperimmune globulins and alpha-1 proteinase inhibitor, and has received the Guangzhou City Science and Technology Award in connection with his work "Preparation of Equine Antibodies against Avian Influenza." Prior to joining China Biologic, Dr. Xie served from 2007 to 2009 as the General Manager of Research and Development at New a-IKOR Limited, a Hong Kong-based biopharmaceutical company, and from 2002 to 2007, as the Director of Research & Development at Advantek Serum Laboratories Limited, a Hong Kong plasma-based biopharmaceutical company. Dr. Xie has also conducted postdoctoral research in various departments in the University of Hong Kong and the Chinese University of Hong Kong.

"We are very pleased to have Dr. Xie join our research team," commented Mr. Chao Ming Zhao, CEO of China Biologic Products. "He brings years of research experience and managerial exper
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit
2. Fauve Intertrade Signs Major Energy Contracts in China
3. China Biologic Products to Participate in the Rodman & Renshaw Annual Global Investment Conference
4. China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes
5. China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports
6. AOBOs Products Included in Chinas Essential Drug List
7. Forty-two of Simceres Generic Drugs Enter Chinas Essential Drug List
8. China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31, 2009 and the First Fiscal Quarter ended June 30, 2009 on September 1, 2009
9. American Oriental Bioengineerings Jinji Capsules and Boke Nasal Spray Designated Among Chinas Top Branded Drugs of 2009
10. China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results
11. China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
(Date:5/21/2013)... 2013 Bed bugs have become so widespread ... Products, many turn to chemical-based pesticides for help to completely ... environmental risks those solutions present, the company advised the public ... instead. , According to My Cleaning Products, chemical-based pesticides ... to be. It shared that the pests have already developed ...
(Date:5/21/2013)... 2013 Inflamax scientists worked closely ... to design the study, which will provide critical ... models used in the study of allergy treatments, ... Challenge (NAC) models. Although both the models are ... date no direct comparison between the allergic responses ...
(Date:5/21/2013)... Boston, MA (PRWEB) May 21, 2013 ... unified communications platform, Microsoft Lync, for customers in Canada. ... communications software and will allow businesses and organizations ... Last month, SoundConnect released Lync in the United ... US, paired with the product release in Canada, SoundConnect ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3
... N.Y., April 9 Is the United ... to study in a post-9/11 America? What,are ... international talent for,American biotechnology research and industrial ... in the department of biomedical,engineering at Boston ...
... acquire common stock held by American Red Cross, in ... ProMetic,s stake in PRDT to 77%, - American Red ... of PRDT, MONTREAL and CAMBRIDGE, England, April 9 ... ProMetic,has signed a Letter of Intent ("LOI") to acquire ...
... Inc. (TSX:,ARI), a biotechnology company discovering and developing the next wave ... Where: St. Andrew,s Club & Conference Centre, S7 ... 150 King Street West, 27th Floor, Toronto, Ontario, When: ... Webcast: ARIUS Research Inc.,s Annual and Special Meeting will be webcast ...
Cached Biology Technology:ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 7ARIUS 2008 Annual and Special Meeting of Shareholders 2
(Date:5/21/2013)... keeping in shape is an uphill battle? Try staying ... prolonged weightlessness withers muscle and bone. , That,s the ... address with a new three-year, $1.2 million grant from ... exercise during multiyear exploratory missions. , "You could give ... you can,t get them to stick to it, it ...
(Date:5/21/2013)... CAMBRIDGE, MA -- Over the past few decades, scientists ... including angioplasty balloons and metallic stents. While generally effective, ... of side effects. , A new study from MIT ... combines the benefits of angioplasty balloons and drug-releasing stents, ... a balloon is inflated in the artery for only ...
(Date:5/21/2013)... Australian scientists have charted the path of insulin action ... provides a comprehensive blueprint for understanding what goes wrong ... Sean Humphrey and Professor David James from Sydney,s Garvan ... early online edition of the prestigious journal Cell ... hormone plays a very important role in the body ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... of Illinois at Chicago have identified a novel function for ... in acute respiratory distress syndrome, also known as ARDS. ... and treatment of lung inflammation and injury. The research will ... this year and online June 29. ARDS is an ...
... exacerbate drought events throughout the world, resulting in large-scale ... addition, periods of drought vary from year to year ... to adapt to more severe conditions. Many modern ... However, evolution and cultivation in the cold, dry Andean ...
... gardens, we watch them turn gradually from hard, green ... This familiar and seemingly commonplace transformation masks a seething ... complex manner. For generations, agriculturalists and scientists have ... nutrient composition, more or less, one trait at a ...
Cached Biology News:UIC researchers make promising finding in severe lung disease 2Drought tolerance in potatoes 2Drought tolerance in potatoes 3The 21st century tomato 2The 21st century tomato 3
... salt solution. It is routinely used as an ... blood at refrigerator temperatures for approximately 10 weeks.1 ... collected into a container of this product and ... in a refrigerator at 2-8 C for 2 ...
... OligoMix or individual RNA sequences from high throughput ... small RNAs from LC Sciences. These products provide ... millions) of DESIGNED sequences delivered in a microtube ... containing a single verified RNA sequence. This is ...
... Chromatograph/Mass Spectrometer, utilizing many of the ... offers high throughput and excellent productivity, ... ratio. Like the GCMS-QP2010 Plus, the ... for optimum separation, 20 temperature ramps, ...
... Assay Kit contains all reagents necessary to ... lineage, as determined by staining for mineralization. ... necessary reagents and a protocol for quantifying ... product is useful for studying the effects ...
Biology Products: